Jemma Arakelyan: Farewell to My Academic Home, Joining a Leader in Anticancer Drug Discovery
Jemma Arakelyan, Chief Executive Officer at The Institute of Cancer and Crisis (ICC) and Medical Advisor at Immune Oncology Research Institute, and Clinical Research Specialist at Laboratory for Synthetic Chemistry and Chemical Biology, shared a post on LinkedIn:
“With a heart full of gratitude, I bid farewell to my academic home at City University of Hong Kong’s Drug Discovery Lab and my mentor, Maria (Masha) Babak, PhD. Thanks for being my scientific mother and guiding me every step of the way.
Now, I’m deeply honored to be joining Professor Chi Ming Che’s team, a pioneering force in anticancer drug discovery. The opportunity to contribute to translating his visionary science into clinical reality is both humbling and exhilarating. I look forward to this new chapter with deep appreciation and great anticipation.
Here’s to new challenges, continued learning, and meaningful impact!”
More posts featuring Jemma Arakelyan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023